Using Surveys to Examine the Association of Exposure to ML Mortality Risk Predictions With Medical Oncologists' Prognostic Accuracy and Decision-making
Clinical trial NCT06463977 · COMPLETED
Trial details
- NCT number
- NCT06463977
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-13
- Primary completion
- 2023-07-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.